tested positive for COVID-19/sick with Covid-19; Stomach ache; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19/sick with Covid-19) and ABDOMINAL PAIN UPPER (Stomach ache) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Cholesterol and Blood pressure. Concomitant products included LISINOPRIL for Blood pressure, SIMVASTATIN for Cholesterol, ACETYLSALICYLIC ACID (ASPIRIN LOW), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and MONASCUS PURPUREUS (RED YEAST RICE) for an unknown indication.   On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jan-2022, the patient experienced COVID-19 (tested positive for COVID-19/sick with Covid-19). In January 2022, the patient experienced ABDOMINAL PAIN UPPER (Stomach ache). In January 2022, COVID-19 (tested positive for COVID-19/sick with Covid-19) and ABDOMINAL PAIN UPPER (Stomach ache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Jan-2022, SARS-CoV-2 test: (Positive) Tested positive with for COVID-19 with rapid testing.         The patient took Lisinopril and Simvastatin like a year apart as his health was really good until he started gaining weight so in last couple years. The patient was taking Red yeast for long time. On an unknown date in Jan-2021 the patient had  fever and stomachache and within a week patient was fine. The patient recovered completely and only had a fever for a day or two and some stomach trouble. The patient recovered fast with no coughing or other symptoms. Patient recovered in 2 weeks and did not went to hospital. Treatment information was not provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  Company Comment: This is a spontaneous case concerning a 58-year-old male patient with no relevant medical history, who experienced the unexpected, non-serious adverse event of special interest of COVID-19 (with SARS-CoV-2 test positive), approximately 7 months after receiving the second dose of mRNA-1273 vaccine. The patient had symptoms of fever and stomach ache and recovered after 2 weeks without treatment. The benefit-risk relationship of mRNA-1273 is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 25-Aug-2022: Follow up document was received and contains no significant information. Narrative was updated.; Sender's Comments: This is a spontaneous case concerning a 58-year-old male patient with no relevant medical history, who experienced the unexpected, non-serious adverse event of special interest of COVID-19 (with SARS-CoV-2 test positive), approximately 7 months after receiving the second dose of mRNA-1273 vaccine. The patient had symptoms of fever and stomach ache and recovered after 2 weeks without treatment. The benefit-risk relationship of mRNA-1273 is not affected by this report.